[1] KOOIMAN J,SETH M,NALLAMOTHU B K,et al.Association between acute kidney injury and in-hospital mortality in patients undergoing percutaneous coronary interventions[J].Circ Cardiovasc Interv,2015,8(6):e002212.
[2] 唐庚,马根山.造影剂肾病防治的研究进展[J].现代医学,2017,45(11):1691-1695.
[3] ZHANG W F,ZHANG T,DING D,et al.Use of both serum cystatin c and creatinine as diagnostic criteria for contrast-induced acute kidney injury and its clinical implications[J].J Am Heart Assoc,2017,6(1):e004747.
[4] NIEHRS C.Function and biological roles of the Dickkopf family of Wnt modulators[J].Oncogene,2006,25(57):7469-7481.
[5] LIU Q W,LI J Y,ZHANG X C,et al.Human amniotic mesenchymal stem cells inhibit hepatocellular carcinoma in tumour-bearing mice[J].J Cell Mol Med,2020,24(18):10525-10541.
[6] LEVIN A,TONELLI M,BONVENTRE J,et al.Global kidney health 2017 and beyond:a roadmap for closing gaps in care,research,and policy[J].Lancet,2017,390(10105):1888-1917.
[7] ZEWINGER S,RAUEN T,RUDNICKI M,et al.Dickkopf-3(DKK3) in urine identifies patients with short-term risk of eGFR loss[J].J Am Soc Nephrol,2018,29(11):2722-2733.
[8] SCHUNK S J,ZARBOCK A,MEERSCH M,et al.Association between urinary dickkopf-3,acute kidney injury,and subsequent loss of kidney function in patients undergoing cardiac surgery:an observational cohort study[J].Lancet,2019,394(10197):488-496.
[9] KELLUM J A,LAMEIRE N.Diagnosis,evaluation,and management of acute kidney injury:a KDIGO summary (Part 1)[J].Critical Care,2013,17(1):204.
[10] MURRAY P T,MEHTA R L,SHAW A,et al.Potential use of biomarkers in acute kidney injury:report and summary of recommendations from the 10th acute dialysis quality initiative consensus conference[J].Kidney Int,2014,85(3):513-521.
[11] BRIGUORI C,VISCONTI G,RIVERA N V,et al.Cystatin C and contrast-induced acute kidney injury[J].Circulation,2010,121(19):2117-2122.
[12] QUINTAVALLE C,ANSELMI C V,DE MICCO F,et al.Neutrophil gelatinase-associated lipocalin and contrast-induced acute kidney injury[J].Circ Cardiovasc Interv,2015,8(9):e002673.
[13] PARIKH C R,LIU C,MOR M K,et al.Kidney biomarkers of injury and repair as predictors of contrast-associated AKI:a substudy of the PRESERVE trial[J].Am J Kidney Dis,2020,75(2):187-194.
[14] NELSON P J,VON TOERNE C,GRÖNE H J.Wnt-signaling pathways in progressive renal fibrosis[J].Expert Opin Ther Targets,2011,15(9):1073-1083.
[15] 许为佳,李涛,费沛,等.DKK3在慢性肾小球肾炎中表达及诱导肾小球足细胞迁移的机制研究[J].临床肾脏病杂志,2019,19(3):181-186.
[16] PIEK A,SMIT L,SUTHAHAR N,et al.The emerging plasma biomarker Dickkopf-3(DKK3) and its association with renal and cardiovascular disease in the general population[J].Sci Rep,2021,11(1):8642.
[17] NUSSE R,CLEVERS H.Wnt/β-catenin signaling,disease,and emerging therapeutic modalities[J].Cell,2017,169(6):985-999.
[18] LIPPHARDT M,DIHAZI H,JEON N L,et al.Dickkopf-3 in aberrant endothelial secretome triggers renal fibroblast activation and endothelial-mesenchymal transition[J].Nephrol Dial Transplant,2019,34(1):49-62.
[19] FEDERICO G,MEISTER M,MATHOW D,et al.Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis[J].JCI Insight,2016,1(1):e84916.
[20] FANG X,HU J,CHEN Y,et al.Dickkopf-3:Current Knowledge in Kidney Diseases[J].Front Physiol,2020,11:533344.
[21] SÁNCHEZ-ÁLAMO B,GARCÍA-IÑIGO F J,SHABAKA A,et al.Urinary Dickkopf-3:a new biomarker for CKD progression and mortality[J].Nephrol Dial Transplant,2021,36(12):2199-2207.
[22] ROSCIGNO G,QUINTAVALLE C,BIONDI-ZOCCAI G,et al.Urinary Dickkopf-3 and contrast-associated kidney damage[J].J Am Coll Cardiol,2021,77(21):2667-2676.
[23] SEIBERT F S,HERINGHAUS A,PAGONAS N,et al.Dickkopf-3 in the prediction of contrast media induced acute kidney injury[J].J Nephrol,2021,34(3):821-828.
[24] ALMENDAREZ M,GURM HS,MARIANI J,et al.Procedural strategies to reduce the incidence of contrast-induced acute kidney injury during percutaneous coronary intervention[J].JACC Cardiovasc Interv,2019,12(19):1877-1888. |